Associations among serum lipoprotein(a) levels, apolipoprotein(a) phenotypes, and myocardial infarction in patients with extremely low and high levels of serum lipoprotein(a)
- PMID: 10496479
- DOI: 10.1253/jcj.63.659
Associations among serum lipoprotein(a) levels, apolipoprotein(a) phenotypes, and myocardial infarction in patients with extremely low and high levels of serum lipoprotein(a)
Abstract
A high serum lipoprotein(a) [Lp(a)] level, which is genetically determined by apolipoprotein(a) [apo(a)] size polymorphism, is an independent risk factor for coronary atherosclerosis. However, the associations among Lp(a) levels, apo(a) phenotypes, and myocardial infarction (MI) have not been studied. Patients with MI (cases, n = 101, M/F: 86/15, age: 62+/-10y) and control subjects (n = 92, M/F: 53/39, age: 58+/-14y) were classified into quintile groups (Groups I to V) according to Lp(a) levels. Apo(a) isoform phenotyping was performed by a sensitive, high-resolution technique using sodium dodecyl sulfate-agarose/gradient polyacrylamide gel electrophoresis (3-6%), which identified 26 different apo(a) phenotypes, including a null type. Groups with higher Lp(a) levels (Groups II, III, and V) had higher percentages of MI patients than that with the lowest Lp(a) levels (Group I) (54%, 56%, or 75% vs. 32%, p<0.05). Groups with different Lp(a) levels had different frequency distributions of apo(a) isoprotein phenotypes: Groups II, III, IV, and V, which had increasing Lp(a) levels, had increasingly higher percentages of smaller isoforms (A1-A4, A5-A9) and decreasingly lower percentages of large isoforms (A10-A20, A21-A25) compared to Group I. An apparent inverse relationship existed between Lp(a) and the apo(a) phenotype. Subjects with the highest Lp(a) levels (Group V) had significantly (p<0.05) higher serum levels of total cholesterol, apo B, and Lp(a). Patients with MI and the controls had different distributions of apo(a) phenotypes: i.e., more small isoforms and more large size isoforms, respectively (A1-A4/A5-A9/A10-A20/A21-A25: 35.7%/27.7%/20.8%/15.8% and 22.8%/23.9%/29.4%/23.9%, respectively). Lp(a) (parameter estimate +/- standard error: 0.70+/-0.20, Wald chi2 = 12.4, p = 0.0004), apo(a) phenotype (-0.43+/-0.15, Wald chi2 = 8.17, p = 0.004), High-density lipoprotein-cholesterol, apo A-I, and apo B were significantly associated with MI after adjusting for age, gender, and conventional risk factors, as assessed by a univariate logistic regression analysis. The association between Lp(a) and MI was independent of the apo(a) phenotype, but the association between the apo(a) phenotype and MI was not independent of Lp(a), as assessed by a multivariate logistic regression analysis. This association was not influenced by other MI- or Lp(a)-related lipid variables. These results suggest that apo(a) phenotype contributes to, but does not completely explain, the increased Lp(a) levels in MI. A stepwise logistic regression analysis with and without Lp(a) in the model identified Lp(a) and the apo(a) phenotype as significant predictors for MI, respectively.
Similar articles
-
Heterozygous apolipoprotein (a) status and protein expression as a risk factor for premature coronary heart disease.J Lab Clin Med. 2002 Mar;139(3):181-7. doi: 10.1067/mlc.2002.121770. J Lab Clin Med. 2002. PMID: 11944029
-
[Relation of pentanucleotide repeat polymorphism of apolipoprotein (a) gene to plasma lipoprotein (a) level among Chinese patients with myocardial infarction and cerebral infarction].Zhonghua Yi Xue Za Zhi. 2002 Oct 25;82(20):1396-400. Zhonghua Yi Xue Za Zhi. 2002. PMID: 12509922 Chinese.
-
Lipoprotein(a) serum concentration and apolipoprotein(a) phenotype correlate with severity and presence of ischemic cerebrovascular disease.Stroke. 1995 Oct;26(10):1841-8. doi: 10.1161/01.str.26.10.1841. Stroke. 1995. PMID: 7570736
-
Dyslipidemia and nephrotic syndrome: recent advances.J Ren Nutr. 2005 Apr;15(2):195-203. doi: 10.1053/j.jrn.2004.10.003. J Ren Nutr. 2005. PMID: 15827892 Review.
-
Lipoprotein Lp(a) and atherothrombotic disease.Arch Med Res. 2000 Jul-Aug;31(4):353-9. doi: 10.1016/s0188-4409(00)00084-9. Arch Med Res. 2000. PMID: 11068075 Review.
Cited by
-
Plasma lipoprotein(a) levels in patients with slow coronary flow.Postepy Kardiol Interwencyjnej. 2013;9(4):323-7. doi: 10.5114/pwki.2013.38404. Epub 2013 Nov 18. Postepy Kardiol Interwencyjnej. 2013. PMID: 24570746 Free PMC article.
-
The role of lipoprotein[a] in atherosclerosis.Curr Atheroscler Rep. 2000 May;2(3):243-50. doi: 10.1007/s11883-000-0026-z. Curr Atheroscler Rep. 2000. PMID: 11122750 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous